LLLuz Marina Leegstra

Luz Marina Leegstra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luz Marina Leegstra has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    “It is not something you like to hear, but it is something you have to know”. Community preferences for risk communication during pregnancy in the context of an emerging pathogen: a multicountry qualitative study with women in three ZIKV endemic countries who were pregnant during and following ZIKV

    by María Consuelo Miranda Montoya, Claudia Milena Hormiga Sánchez, Ester Paiva Souto, Edna Acosta Pérez, Gustavo Matta, Juliana Silva Corrêa, Marcela Daza, Gabriela Gama, Camila Pimentel, Marcela Mercado-Reyes, et al.

    Introduction: Community values and preferences should inform risk communication during pregnancy in the context of an epidemic of an emerging pathogen, given the high levels of uncertainty in the diagnosis and the probability of an adverse outcome. Methods: We conducted a multicountry qualitative study with 98 women from 7 sites in Brazil, Colombia and Puerto Rico to understand their preferences for learning about Zika virus test results amid high levels of uncertainty in diagnostic testing and related outcomes. We used thematic analysis with a combined deductive and inductive approach to analyse findings from the in-depth interviews. Findings: Across sites and time periods, women wanted to learn about their test results, the risk to their pregnancy or infant and the related uncertainty as early as possible. They wanted to separate risk communication from decision-making around the following steps to give them time to consider the test results, related risks and available services. Conclusions: Communication of the risk associated with an emerging pathogen suspected to affect pregnancy and developmental outcomes is a fraught issue. Public health authorities and healthcare providers should work closely together to understand families’ preferences for risk communication in the presence of uncertainty and develop a community-informed plan for risk communication as early as possible during an epidemic of an emerging infectious disease.

  • Open Access

    “I found out about Zika virus after she was born.” Women’s experiences of risk communication during the Zika virus epidemic in Brazil, Colombia, and Puerto Rico

    by María Consuelo Miranda Montoya, Claudia Hormiga Sánchez, Ester Paiva Souto, Edna Acosta Pérez, Gustavo Corrêa Matta, Marcela Daza, Gabriela Lopes Gama, Camila Pimentel, Marcela Mercado, Angélica María Amado Niño, et al.

    Providing accurate, evidence-based information to women with Zika infection during pregnancy was problematic because of the high degree of uncertainty in the diagnosis of the infection and the associated risk. The 2015–17 Zika virus epidemic overwhelmingly affected women in countries with limited access to safe abortion. Understanding women’s perspectives on risk communication during pregnancy in the context of an emerging pathogen can help inform risk communication in response to future outbreaks that affect fetal or child development. We conducted a cross-sectional qualitative interview study with 73 women from 7 locations in Brazil, Colombia, and Puerto Rico to understand women’s experiences of Zika virus (ZIKV) test and outcome-related communication during the ZIKV pandemic. We used thematic analysis to analyze the in-depth interviews. Participants in Brazil and Colombia reported that the healthcare system’s lack of preparation and organization in communicating ZIKV test results and associated adverse outcomes led to their feeling abandoned and alone in confronting the challenges of a ZIKV-affected pregnancy. In contrast, participants in Puerto Rico reported that the regular testing schedules and clear, well-planned communication between the care team and between providers and pregnant women helped them to feel they could prepare for a ZIKV-affected pregnancy. Communication of the risk associated with an emerging pathogen suspected to affect pregnancy and developmental outcomes is a fraught issue. Public health authorities and healthcare providers should work together in the interpandemic period to understand families’ preferences for risk communication during pregnancy in the presence of uncertainty and develop a community-informed plan for risk communication.


  • Open Access

    “I found out about Zika virus after she was born.” Women’s experiences of risk communication during the Zika virus epidemic in Brazil, Colombia, and Puerto Rico

    by María Consuelo Miranda, Claudia Hormiga Sánchez, Ester Paiva Souto, Edna Acosta Pérez, Gustavo Corrêa Matta, Marcela Daza, Gabriela Lopes Gama, Camila Pimentel, Marcela Mercado, Angélica María Amado Niño, et al.

    Introduction: Providing accurate, evidence-based information to women with Zika infection during pregnancy was problematic because of the high degree of uncertainty in the diagnosis of the infection and the associated risk. The 2015-17 Zika virus epidemic overwhelmingly affected women in countries with limited access to safe abortion. Understanding women’s perspectives on risk communication during pregnancy in the context of an emerging pathogen can help inform risk communication in response to future outbreaks that affect fetal or child development. Methods: We conducted a cross-sectional qualitative interview study with 73 women from 7 locations in Brazil, Colombia, and Puerto Rico to understand women’s experiences of ZIKV test and outcome-related communication during the ZIKV pandemic. We used thematic analysis to analyze the in-depth interviews. Findings: Participants in Brazil and Colombia reported that the healthcare system’s lack of preparation and organization in communicating ZIKV test results and associated adverse outcomes led to their feeling abandoned and alone in confronting the challenges of a ZIKV-affected pregnancy. In contrast, participants in Puerto Rico reported that the regular testing schedules and clear, well-planned communication between the care team and between providers and pregnant women helped them to feel they could prepare for a ZIKV-affected pregnancy. Conclusion: Communication of the risk associated with an emerging pathogen suspected to affect pregnancy and developmental outcomes is a fraught issue. Public health authorities and healthcare providers should work together in the interpandemic period to understand families’ preferences for risk communication during pregnancy in the presence of uncertainty and develop a community-informed plan for risk communication.

  • Open Access

    "How about me giving blood for the COVID vaccine and not being able to get vaccinated?" A cognitive interview study on understanding of and agreement with broad consent for future use of data and samples in Colombia and Nicaragua

    by Lauren Maxwell, Jackeline Bravo Chamorro, Luz Marina Leegstra, Harold Suazo Laguna, María Consuelo Miranda Montoya

    Broad consent for future use, wherein researchers ask participants for permission to share participant-level data and samples collected within the study for purposes loosely related to the study objectives, is central to enabling ethical data and sample reuse. Ensuring that participants understand broad consent-related language is key to maintaining trust in the study and public health research. We conducted 52 cognitive interviews to explore cohort research participants’ and their parents’ understanding of the broad consent-related language in the University of California at Berkeley template informed consent (IC) form for biomedical research. Participants and their parents were recruited from long-standing infectious disease cohort studies in Nicaragua and Colombia and interviewed during the COVID-19 pandemic. We conducted semi-structured interviews to assess participants’ agreement with the key concepts in the IC after clarifying them through the cognitive interview. Participants did not understand abstract concepts, including collecting and reusing genetic data. Participants wanted to learn about incidental findings, future users and uses. Trust in the research team and the belief that sharing could lead to new vaccines or treatments were critical to participant support for data and sample sharing. Participants highlighted the importance of data and sample sharing for COVID-19 response and equitable access to vaccines and treatments developed through sharing. Our findings on participants’ understanding of broad consent and preferences for data and sample sharing can help inform researchers and ethics review committees working to enable ethical and equitable data and sample sharing.


  • Open Access

    “How about me giving blood for the COVID vaccine and not being able to get vaccinated?” A cognitive interview study on understanding of and agreement with broad consent for future use with cohort participants and guardians in Colombia and Nicaragua

    by Lauren Maxwell, Jackeline Bravo Chamorro, Luz Marina Leegstra, Harold Suazo Laguna, María Consuelo Miranda Montoya

    Informed consent (IC) is key to generating and maintaining research participants’ trust and upholding the ethical principle of autonomy. Broad consent for future use, wherein researchers ask participants for permission to share participant-level data and samples collected within the study for purposes loosely related to the study objectives, is central to enabling ethical data and sample reuse. Ensuring that participants understand broad consent-related language is key in maintaining trust in the study itself and in public health research generally. Therefore, we conducted 52 cognitive interviews with the help of semi-structured interview guides to explore cohort research participants’ understanding of the broad consent-related language in the University of California at Berkeley template IC form for biomedical research with participants from long-standing infectious disease cohort studies in Nicaragua and Colombia. After the first round of interviews, we used participants’ explanations to modify the broad consent-related language in the IC template and consequently re-evaluated participants’ understanding of and agreement with the new consent form. Participants generally supported data and sample sharing but expressed concerns about the intentions of for-profit groups as well as misuse of data or samples. Moreover, they felt uncomfortable not receiving information about incidental findings and results from future studies. Cohort participants did not understand abstract concepts including the collection and reuse of genetic data in either version of the IC. Trust in the research team and the belief that data and sample sharing could lead to new scientific insights and improved treatments were key to participant support for data and sample sharing. The study findings and research participants’ language to describe broad consent provide essential insights for researchers who want to include broad consent and ethics review committees (ERCs) working to ensure research is conducted in keeping with the ethical principle of respect for persons. Author Summary This is the first study to apply cognitive interviewing to evaluate participants’ understanding of broad consent. We found that cohort participants did not well understand the broad consent-related language in the UCB template IC. When broad consent was reworded with language from the community, difficult to process concepts, like genetic studies, were better understood. Many ethics review committees (ERCs) and universities require researchers to use a template when consenting participants for participation in biomedical research. Our finding that key concepts in the broad consent section of the template, including genetic studies and sample collection, were not well understood suggests that ERCs must allow researchers flexibility to alter IC template language to ensure participant understanding. While, like many ERCs, the University of California at Berkeley (UCB) recommends that researchers not communicate incidental findings, participants did not understand that incidental findings would not be shared and universally wanted to learn about incidental findings. Participants generally believed in the utility of data and sample reuse but expressed concerns about reuse by commercial groups and wanted to better understand who and what the future users were. Participants did not mention privacy as a concern in data and sample sharing. Informing participants about incidental findings and future uses and users is an important part of maintaining trust in data and sample sharing.

  • Open Access

    How Do Ethics Review Committee Members Weigh the Risks and Benefits of Broad Consent for Data and Sample Sharing During a Pandemic? A Cross-Sectional, Qualitative Study in Colombia

    by María Consuelo Miranda Montoya, Jackeline Bravo Chamorro, Luz Marina Leegstra, Deyanira Duque Ortiz, Lauren Maxwell

    Background: Broad consent for future use facilitates the reuse of participant-level data and samples, which can conserve limited resources by confirming research findings and facilitate the development and evaluation of public health and clinical advances. Ethics review committees (ERCs) have to balance different stakeholder concerns when evaluating the risks and benefits associated with broad consent for future use. In this qualitative study, we evaluated ERC members' concerns about different aspects of broad consent, including appropriate governance, community engagement, evaluation of risks and benefits, and communication of broad consent for future use in Colombia, which does not currently have national guidance related to broad consent for future use. Methods: We conducted semi-structured, in-depth interviews with 24 ERC members from nine Colombian ERCs. We used thematic analysis to explore ERC members' concerns related to broad consent for future use. Findings: Most ERC members expressed concern about the idea of not specifying the purposes for which data would be used and by whom and suggested that pre-specifying governance procedures and structure would address some of their concerns about broad consent. ERC members emphasized the need for engaging communities and ensuring research participants understood broad consent for future use-related language in informed consent forms. Interpretation: Researchers and research institutions are under increasing pressure to share public health-related data. ERC members play a central role in balancing the priorities of different stakeholders and maintaining their community's trust in public health research. Further work is needed on guidelines for developing language around broad consent, evaluating community preferences related to data sharing, and developing standards for describing governance for data or sample sharing in the research protocol to address ERC members' concerns around broad consent for future use. Funding Information: TDR, the Special Programme for Research and Training in Tropical Diseases, grant to L.M. [P20-00007]; ReCoDID project, funded by the EU Horizon 2020 research and innovation programme (grant agreement 825746) and the CIHR Institute of Genetics (grant agreement 01886-000) grant to L.M. Declaration of Interests: We declare no competing interests. Ethics Approval Statement: The research protocol was approved by the Ethics Review Committee of the Centro de Atención de Diagnóstico de Enfermedades Infecciosas, Bucaramanga, Colombia.